Search by Drug Name or NDC

    NDC 00338-9553-24 clindamycin phosphate 900 mg/50mL Details

    clindamycin phosphate 900 mg/50mL

    clindamycin phosphate is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is CLINDAMYCIN PHOSPHATE.

    Product Information

    NDC 00338-9553
    Product ID 0338-9553_ed5b6988-2a59-4c71-93f1-53e2de0d4477
    Associated GPIs 16220020322020
    GCN Sequence Number 077327
    GCN Sequence Number Description clindamycin in 0.9 % sod chlor PIGGYBACK 900MG/50ML INTRAVEN
    HIC3 W1K
    HIC3 Description LINCOSAMIDE ANTIBIOTICS
    GCN 43307
    HICL Sequence Number 012827
    HICL Sequence Number Description CLINDAMYCIN PHOSPHATE IN 0.9 % SODIUM CHLORIDE
    Brand/Generic Generic
    Proprietary Name clindamycin phosphate
    Proprietary Name Suffix n/a
    Non-Proprietary Name clindamycin phosphate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 900
    Active Ingredient Units mg/50mL
    Substance Name CLINDAMYCIN PHOSPHATE
    Labeler Name Baxter Healthcare Corporation
    Pharmaceutical Class Decreased Sebaceous Gland Activity [PE], Lincosamide Antibacterial [EPC], Lincosamides [CS], Neuromuscular Blockade [PE]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA208083
    Listing Certified Through 2024-12-31

    Package

    NDC 00338-9553-24 (00338955324)

    NDC Package Code 0338-9553-24
    Billing NDC 00338955324
    Package 24 BAG in 1 CARTON (0338-9553-24) / 50 mL in 1 BAG (0338-9553-50)
    Marketing Start Date 2017-04-20
    NDC Exclude Flag N
    Pricing Information N/A